Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 17, 2018, 01:18 ET Novartis granted US FDA Priority Review for Kymriah™ (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL

Novartis today announced that its supplemental Biologics License Application (sBLA) for Kymriah™ (tisagenlecleucel) suspension for intravenous...


Jan 17, 2018, 01:00 ET Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announced today that the U.S. Food and Drug Administration (FDA) has...


Jan 16, 2018, 13:00 ET goBalto Joins The Avoca Quality Consortium

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its membership in The Avoca Quality Consortium...


Jan 16, 2018, 11:00 ET Thirty-Year National Study Shows Women Who Breastfeed Six Months or More Reduce Their Diabetes Risk by 50 Percent

Breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years,...


Jan 16, 2018, 10:56 ET New Year Rings In New Hope for People with Lupus

Singer Selena Gomez brought lupus awareness to new heights in early 2017 when she shared her compelling story about having a kidney transplant...


Jan 16, 2018, 09:00 ET MyDx's Biopharmaceutical Division Commences Clinical Trials On Its Unique MyDx360 Pain Management Formula

MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer...


Jan 16, 2018, 08:54 ET Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs

Scientific progress and new drug innovation don't take place in a vacuum. The exchange of information that informs decisions to undertake research,...


Jan 16, 2018, 08:30 ET MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix® Injectable In Patients With Recalcitrant Plantar Fasciitis Pain

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing...


Jan 16, 2018, 08:30 ET Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today reported a heavy schedule of meetings throughout the four-day conference, predominately with...


Jan 16, 2018, 08:00 ET CompleWare and YPrime Announce Partnership Agreement

CompleWare and YPrime announce a partnership agreement to deliver enhanced service offerings involving clinical trials, electronic clinical outcome...


Jan 16, 2018, 08:00 ET Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint

Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced...


Jan 16, 2018, 07:30 ET MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to...


Jan 16, 2018, 07:00 ET Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell selection technology, announced that it has signed an agreement with...


Jan 16, 2018, 01:54 ET APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease

APRINOIA Therapeutics Inc., a clinical-stage neuroscience biotech company, focuses on tau, alpha-synuclein, and novel targets for neurodegenerative...


Jan 16, 2018, 01:21 ET Novartis new data reinforces superiority of Cosentyx® versus Stelara® in achieving skin clearance for psoriasis patients

Novartis announced today results from the head-to-head CLARITY study demonstrating the superiority of Cosentyx® (secukinumab) compared to Stelara®...


Jan 15, 2018, 09:15 ET Une solution d'ingénierie conçue par les scientifiques de NUST MISIS va significativement réduire les coûts de la recherche sur l'IRM

Des chercheurs du Centre d'ingénierie pour les technologies industrielles de NUST MISIS ont mis au point une technologie novatrice destinée à...


Jan 15, 2018, 09:10 ET NUST MISIS-Wissenschaftler entwickeln technische Lösung, die bedeutende Kosteneinsparungen bei der MRT-Forschung ermöglicht

Forscher am NUST MISIS Engineering Center for Industrial Technologies haben eine innovative Technologie für die Herstellung magnetischer...


Jan 15, 2018, 08:30 ET Castle Creek Pharmaceuticals Announces Data Validating First Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research

Castle Creek Pharmaceuticals (CCP), a global biotech company dedicated to delivering transformative therapies to patients with orphan dermatologic...


Jan 15, 2018, 08:30 ET USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine...


Most Viewed